Navigation Links
Alcoa Unveils Partnership for Carbon Capture Technology Pilot Test Designed to Turn Emissions Into Beneficial Commercial Products
Date:4/7/2011

NEW YORK, April 7, 2011 /PRNewswire/ -- Alcoa (NYSE: AA) today announced a new pilot program, in collaboration with Codexis, Inc. (Nasdaq: CDXS) and CO2 Solution Inc. (TSX-V: CST), focused on carbon capture technology designed to sequester industrial carbon emissions, neutralizing the material to create a commercially viable product.

The project is the latest innovation from the world's leading aluminum producer and will be funded by Alcoa along with approximately $13.5 million in funding from the U.S. Department of Energy (DOE) received from an award with the National Energy Technology Laboratory (NETL). This funding was made available by the American Recovery and Reinvestment Act (ARRA).

The pilot program, part of Alcoa's ongoing commitment to enhance its operational sustainability, will use an innovative and proprietary in-duct scrubber technology to capture emissions. The collaboration is intended to devise solutions that treat and utilize a primary byproduct of the aluminum manufacturing process known as alkaline clay, or bauxite residue, as well as other alkaline industrial residuals. This pilot project will test a scrubbing process that combines treated flue gas, enzymes and alkaline clay to create a mineral-rich neutralized product that could be used for environmental reclamation projects. The project is emblematic of how Alcoa is leveraging its extensive R&D capabilities and utilizing game-changing technologies from companies such as Codexis and CO2 Solution to advance sustainable solutions that can have an impact beyond Alcoa's operations.

"Our mission at Alcoa is to create a more sustainable world through innovative solutions and responsible operations," said Kevin Anton, Alcoa's Chief Sustainability Officer. "Finding ways to turn industrial waste into beneficial products will create a more sustainable society for generations to come. We are committed to this project and partnership because it epitomizes our belief that sustainable technologies are fundamental for the maintenance of vital resources and, therefore, for our business."

Scientists and engineers from Alcoa Technical Center in Pittsburgh will lead the three-year project, which has an investigation phase that runs through December.  Upon successful completion of this phase, the project will proceed to the pilot testing phase. The DOE grant was received as part of an initiative to find ways of converting captured carbon dioxide emissions from industrial sources into useful products such as fuels, plastics, cement and fertilizers.  

"We are very pleased to be expanding deployment of our carbon capture technology with Alcoa," said Dr. Alan Shaw, Codexis president and CEO. "We recently reported significant progress in our first program to reduce CO2 emissions from coal-fired power plants. With this agreement, we are expanding to a second large market where our technology can add real economic value, and where it may convert industrial waste to new, valuable products."

Glenn Kelly, CO2 Solution president and CEO, commented on the new partnership, saying, "We are delighted to be building on our relationship with Alcoa to support this important technology development and further expand into U.S. and global markets. This represents a significant new application of our technology, and we are pleased to be working with Alcoa as a global leader towards its realization."

Codexis and CO2 Solution have been collaborating since late 2009 on the development of custom carbonic anhydrase (CA) enzymes and processes that could significantly decrease the cost of carbon dioxide capture from industrial sources. CA is an enzyme that catalyzes the transfer of carbon dioxide in nature, and program results to date show that the technology can be used to create and deploy CA biocatalysts with substantially improved stability and performance under industrial conditions.

For more information, visit www.alcoa.com, www.codexis.com and www.co2solution.com.

About Alcoa Alcoa is the world's leading producer of primary aluminum, fabricated aluminum and alumina. In addition to inventing the modern-day aluminum industry, Alcoa innovation has been behind major milestones in the aerospace, automotive, packaging, building and construction, commercial transportation, consumer electronics and industrial markets over the past 120 years. Among the solutions Alcoa markets are flat-rolled products, hard alloy extrusions, and forgings, as well as Alcoa® wheels, fastening systems, precision and investment castings, and building systems in addition to its expertise in other light metals such as titanium and nickel-based super alloys. Sustainability is an integral part of Alcoa's operating practices and the product design and engineering it provides to customers. Alcoa has been a member of the Dow Jones Sustainability Index for eight consecutive years and approximately 75 percent of all of the aluminum ever produced since 1888 is still in active use today. Alcoa employs approximately 59,000 people in 31 countries across the world. More information can be found at www.alcoa.com.

About Codexis, Inc.Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and in carbon capture. Other potential markets include chemicals and water treatment. For more information, see www.codexis.com.

Codexis Forward-Looking StatementsThis press release contains forward-looking statements relating to Codexis' research in carbon capture technology.  You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis' Annual Report on Form 10-K dated February 10, 2011 including under the caption "Risk Factors." Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

About CO2 Solution Inc.CO2 Solution is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for power plants and other large stationary sources of carbon pollution.  In the process, CO2 Solution has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post-combustion capture of carbon dioxide with low-energy aqueous solvents.  Further information about CO2 Solution can be found at www.co2solution.com

Forward-looking StatementsCertain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solution's future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solution undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.MEDIA CONTACTS:AlcoaCO2 Solution Inc.Codexis, Inc.Mike Belwood

+1.812.604.0530

mike.belwood@alcoa.com

Thom Skinner

+1.418.842.3456

thom.skinner@co2solution.com

Lyn Christenson

+1.650.421.8144

lyn.christenson@codexis.com
'/>"/>

SOURCE Alcoa; Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oregon Tourism Commission Unveils New Online Customer Service Training Program
2. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
3. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
4. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
5. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
6. Boehringer Ingelheim Unveils Diabetes Pipeline
7. GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
8. Cleveland Clinic Unveils Top 10 Medical Innovations for 2010
9. Eurotech Unveils New Diabetes Care Management Solution
10. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
11. Siemens Unveils New Hearing Loss Options at SPLASH: ADAs 2009 Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  As people age, it ... multitude of recommended screenings and tests that are linked ... priority. However, for the majority of aging individuals, hearing ... planning. For the 37.5 million American adults who report ... present to make hearing health a 2016 healthy aging ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> Research ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon on January ... year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped to his ... This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap on the ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment and ... clinical and scientific initiatives have all marked the last 12 months at Roswell ... CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the ...
(Date:2/5/2016)... ... , ... Looking for a last-minute Valentine’s Day gift for the special someone ... massage, whether administered by a professional masseuse or a loved one, can bring substantial ... Multiple Specialties in Podiatry (ABMSP) has taken the upcoming Valentine’s Day as an ...
(Date:2/5/2016)... Rafael, CA (PRWEB) , ... February 05, 2016 , ... ... with ChildLight Yoga Studio in Dover, NH to direct high-performance kids yoga training. ChildLight ... New Hampshire’s seacoast, just one hour from Boston. , ChildLight Yoga Studio founder Lisa ...
(Date:2/5/2016)... ... , ... Give To Cure today announced that it is working ... To Cure’s campaign that is crowdfunding clinical trials to help find cures faster for ... a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. ...
Breaking Medicine News(10 mins):